Related Experiment Videos
[A case of pulmonary alveolar microlithiasis]
M Usui1, M Watanabe, J Hattori
1Department of Pneumology, Gifu Red Cross Hospital, Japan.
Summary
This case report details a 42-year-old man diagnosed with pulmonary alveolar microlithiasis after initial misdiagnosis of miliary tuberculosis. The condition remained untreated for 30 years, highlighting a rare, protracted disease course.
Area of Science:
- Pulmonology
- Radiology
- Pathology
Background:
- Pulmonary alveolar microlithiasis (PAM) is a rare lung disease characterized by the accumulation of microliths in the alveoli.
- Accurate diagnosis can be challenging, especially in cases with atypical presentations or long-standing disease.
- This case highlights the importance of considering PAM in patients with persistent respiratory symptoms and a history of misdiagnosis.
Observation:
- A 42-year-old male presented with a 30-year history of pulmonary alveolar microlithiasis, initially misdiagnosed as miliary tuberculosis during childhood.
- Diagnostic workup included chest CT, tomography, pulmonary function tests, radioisotope scans (99mTc and 67Ga), and bronchoscopy with bronchoalveolar lavage (BAL) and transbronchial lung biopsy (TBLB).
- Available chest X-ray films from 27 years prior aided in establishing the protracted nature of the disease.
Findings:
- The patient's pulmonary alveolar microlithiasis followed a 30-year protracted course, underscoring the chronicity of the condition.
- Diagnostic procedures confirmed the presence of microliths within the alveolar spaces.
- The case emphasizes the diagnostic challenges and the need for thorough investigation in long-standing respiratory conditions.
Implications:
- This report contributes to the literature on pulmonary alveolar microlithiasis, particularly concerning its long-term clinical course and diagnostic considerations.
- Accurate and timely diagnosis of PAM is crucial for appropriate patient management and prognosis.
- Further research into the pathogenesis and long-term outcomes of pulmonary alveolar microlithiasis is warranted.